Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 1

Research Article

Grape Seed Procyanidins in Pre- and Mild Hypertension: A Registry Study

Table 1

Key parameters at inclusion, 4, 8, 12, and 16 weeks.

TimeSystolic pressureDiastolic pressureLaser Doppler fluxHeart ratePlasma-free radicals
Enovita 300 mgEnovita 150 mgControlEnovita 300 mgEnovita 150 mgControlEnovita 300 mgEnovita 150 mgControlEnovita 300 mgEnovita 150 mgControlEnovita 300 mgEnovita 150 mgControl

Inclusion149; 4.5150; 3153.3; 4.491; 3.291.3; 290.4; 2.51.1; 0.011.1; 0.21.1; 0.0178; 3.577.3; 477.2; 3.3378; 22382; 21383; 23
4 weeks121.3; 5.4*#129; 2.2*#142.3; 5*86.3; 3.9*88; 2*88.4; 3*1.28; 0.01*#1.2; 0.11.16; 0.0173; 2.2*73; 3.2*74; 3.2*
8 weeks119; 4.9*#125; 3*#142; 3.984.4; 2.8*#86.1; 2.1*87; 3.62.13; 0.1*#1.6; 0.2*#1.22; 0.171; 3.1*73; 2.174; 3.1 324; 19*# 339; 32*# 376; 29*
12 weeks113; 3.3*#122; 3.2*#139; 3.583; 3.3#86.3; 2#88; 2.22.22; 0.2*#1.9; 0.2*#1.3; 0.169; 2.3*72.2; 2#74; 2.3
16 weeks112; 3.5*#123; 2.1*#141; 4.3 82.3; 3#85.3; 2#88.9; 3.2 2.23; 0.1#1.9; 0.2#1.2; 0.170; 1.572; 2.373.2; 2.2317; 22*#342; 28#374; 22

indicates statistical variations in comparison with previous value.
#: better than controls.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.